Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]

Panettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the orig...

Full description

Bibliographic Details
Main Authors: Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Journal of Asthma and Allergy
Subjects:
Online Access:https://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAA
id doaj-3098aa8b71d8474ab1b4dd312f139d67
record_format Article
spelling doaj-3098aa8b71d8474ab1b4dd312f139d672020-11-25T02:25:11ZengDove Medical PressJournal of Asthma and Allergy1178-69652020-03-01Volume 1313513652500Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]Panettieri RA JrWelte TShenoy KVKorn SJandl MKerwin EMFeijoo RBarker POlsson RFMartin UJPanettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the original articlehttps://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAAanti–il-5rαbenralizumabinterleukin-5randomized controlled trialeosinophilicsevere asthma 
collection DOAJ
language English
format Article
sources DOAJ
author Panettieri RA Jr
Welte T
Shenoy KV
Korn S
Jandl M
Kerwin EM
Feijoo R
Barker P
Olsson RF
Martin UJ
spellingShingle Panettieri RA Jr
Welte T
Shenoy KV
Korn S
Jandl M
Kerwin EM
Feijoo R
Barker P
Olsson RF
Martin UJ
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
Journal of Asthma and Allergy
anti–il-5rα
benralizumab
interleukin-5
randomized controlled trial
eosinophilic
severe asthma 
author_facet Panettieri RA Jr
Welte T
Shenoy KV
Korn S
Jandl M
Kerwin EM
Feijoo R
Barker P
Olsson RF
Martin UJ
author_sort Panettieri RA Jr
title Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
title_short Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
title_full Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
title_fullStr Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
title_full_unstemmed Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
title_sort onset of effect, changes in airflow obstruction and lung volume, and health-related quality of life improvements with benralizumab for patients with severe eosinophilic asthma: phase iiib randomized, controlled trial (solana) [corrigendum]
publisher Dove Medical Press
series Journal of Asthma and Allergy
issn 1178-6965
publishDate 2020-03-01
description Panettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.Read the original article
topic anti–il-5rα
benralizumab
interleukin-5
randomized controlled trial
eosinophilic
severe asthma 
url https://www.dovepress.com/corrigendum-onset-of-effect-changes-in-airflow-obstruction-and-lung-vo-peer-reviewed-article-JAA
work_keys_str_mv AT panettierirajr onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT weltet onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT shenoykv onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT korns onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT jandlm onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT kerwinem onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT feijoor onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT barkerp onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT olssonrf onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
AT martinuj onsetofeffectchangesinairflowobstructionandlungvolumeandhealthrelatedqualityoflifeimprovementswithbenralizumabforpatientswithsevereeosinophilicasthmaphaseiiibrandomizedcontrolledtrialsolanacorrigendum
_version_ 1724852495367274496